About Yihao
Shanghai Yihao Biotechnology Co., Ltd. is located in Shanghai Juke Biological Park. It is committed to becoming a practitioner in the field of cell therapy in China, regarding “improving innovative tumor immunotherapy technology” as a concept, an attitude, and a kind of pursuit in order to provide a cutting-edge and accurate treatment plan for cancer patients.
More
Stem cells and their derivatives have been known as revolutions in medical history in the 21st century...
The research and development of Yihao's biological tumor immune cell therapy is at the forefront...
For newborn and elder patients, it is often difficult to obtain enough T cells with good quality to...
News
FDA-APPROVED CAR T CELL THERAPY FOR NON-HODGKIN LYMPHOMA
To date, the U.S. Food & Drug Administration (FDA) has approved two forms of CAR T cell therapy for patients with non-Hodgkin lymphoma. City of Hope is one of the only institutions in the United State
2023-06-27
With FDA Approval for Advanced Lymphoma, Second CAR T-Cell Therapy Moves to the Clinic
Just a month after approving the first cancer therapy that uses genetically engineered immune cells collected from patients, the Food and Drug Administration (FDA) has now cleared a second such therap
2023-06-27
Join UCLA pediatric oncologist Satiro De Oliveira, MD, for a discussion about CAR T-cell therapy for pediatric patients, including indications, plan of care, side effects, risks and benefits.
2023-06-27
Address:：4F, Block 1C, No. 218 Yindu Road, Xuhui District, Shanghai Contact:：Miss Jiang
Tel： 021-68811399 Mobile：13601846746 Email：service@yihaobio.com
Copyright: Shanghai Yihao Biological Technology Co., Ltd.
手机二维码
微信二维码